Hem › Lymfom › New York

Kliniska studier för Lymfom i New York

42 studier för Lymfom söker deltagare vid platser i New York.

Städer i New York

Officiell studietext (engelska)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center, New York

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07192471

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
Memorial Sloan Kettering Cancer Center, New York

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07015242

Epco, Zanu, Ritux for R/R FL or MZL

Memorial Sloan Kettering Cancer Center, New York

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06563596

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, East White Plains
Memorial Sloan Kettering Cancer Center, New York
och 1 fler

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT02974647

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
och 1 fler

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT04301076

Collection of Tissue Samples for Cancer Research

Roswell Park Cancer Institute, Buffalo

RekryterarObservationsstudie

2 Months · Alla kön · Uppdaterad 16 sep. 2026 · NCT00900198

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Cornell, New York

RekryterarFas 1

Ålder 18 till 100 · Alla kön · Uppdaterad 15 sep. 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Research Site, New York

RekryterarFas 1/2

Ålder 12 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Roswell Park Cancer Institute, Buffalo
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
och 1 fler

RekryterarFas 1/2

12 Months – 21 Years · Alla kön · Uppdaterad 11 sep. 2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Research Site, Rochester

RekryterarFas 3

Ålder 18 till 18 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stony Brook Univ Cancer Ctr, Stony Brook

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06624085

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine - New York Presbyterian Hospital, New York

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07082803

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Hematology Oncology Associates of Central New York, East Syracuse
University of Rochester, Rochester
Stony Brook University Hospital Cancer Center, Stony Brook

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06084936

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

RekryterarFas 1/2

Ålder 18 och äldre · Alla kön · Uppdaterad 25 aug. 2026 · NCT05826535

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
och 1 fler

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 10 aug. 2026 · NCT05389293

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

RekryterarFas 1/2

Ålder 13 till 90 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Roswell Park Comprehensive Cancer Center, Buffalo

RekryterarFas 3

Ålder 18 och äldre · Alla kön · Uppdaterad 4 aug. 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Memorial Sloan Kettering Cancer Center, New York

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT04792489

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

Memorial Sloan Kettering, New York

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 8 juli 2026 · NCT07465835

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Call for Information (Investigational Site 0031), New York

RekryterarFas 1/2

6 Months – 17 Years · Alla kön · Uppdaterad 6 juli 2026 · NCT02332668

CD4CAR for CD4+ Leukemia and Lymphoma

Albert Einstein Health Network, New York

RekryterarFas 1

Ålder 12 och äldre · Alla kön · Uppdaterad 24 juni 2026 · NCT03829540

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Investigational Site 1, New York
Dren Investigational Site 2, New York

RekryterarFas 1/2

Ålder 18 och äldre · Alla kön · Uppdaterad 17 juni 2026 · NCT05475925

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
och 1 fler

RekryterarFas 1

Ålder 18 och äldre · Alla kön · Uppdaterad 5 juni 2026 · NCT07137494

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Mount Sinai Hospital, New York
Memorial Sloan Kettering Cancer Center, New York

RekryterarObservationsstudie

Ålder 18 och äldre · Alla kön · Uppdaterad 1 juni 2026 · NCT05663502

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Columbia University Irving Medical Center, New York

RekryterarFas 2

Ålder 15 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT06954805

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
och 1 fler

RekryterarFriska volontärer välkomna

Ålder 18 och äldre · Alla kön · Uppdaterad 26 maj 2026 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
University of Rochester, Rochester
Stony Brook University Medical Center, Stony Brook
och 1 fler

RekryterarObservationsstudie

Alla åldrar · Alla kön · Uppdaterad 18 maj 2026 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

RekryterarFas 2

Upp till ålder 26 · Alla kön · Uppdaterad 14 maj 2026 · NCT07566377

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Roswell Park Comprehensive Cancer Center, Buffalo
Mt Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

RekryterarFas 1/2

Ålder 18 och äldre · Alla kön · Uppdaterad 16 apr. 2026 · NCT03328078

Study of CAR-T Therapy in Older Patients

Memorial Sloan Kettering Cancer Center, New York

RekryterarObservationsstudie

Ålder 60 och äldre · Alla kön · Uppdaterad 7 apr. 2026 · NCT04300998

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Memorial Sloan Kettering, New York

RekryterarFas 2

Ålder 18 till 66 · Alla kön · Uppdaterad 17 mars 2026 · NCT06859424

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Icahn School of Medicine at Mount Sinai, New York

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT06510361

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
och 1 fler

RekryterarFas 2

Ålder 18 och äldre · Alla kön · Uppdaterad 5 mars 2026 · NCT06698003